Sudarshan Chemical Q2 FY27 Investor Presentation: Consolidated Results Overview
Sudarshan Chemical Industries Limited released its Q2 FY27 investor presentation on November 6, 2026. Consolidated revenue from operations was ₹868 crore (up 22.0% YoY) with reported EBITDA at ₹126 crore (up 38.6% YoY). The company completed an acquisition for CHF 7 million and a sale for EUR 75.8 million. FY27 guidance for the Acquired Group is €700 million sales and €35 million EBITDA.
The announcement contains detailed financial results for the quarter and half-year, significant corporate actions (acquisition and divestiture), and forward-looking guidance. These are material events that can significantly influence investor decisions and the company's stock performance.
The company reported significant year-on-year growth in revenue and EBITDA for both Q2 and H1 FY27 on a consolidated basis. Key strategic acquisitions and divestitures were successfully completed, strengthening the balance sheet and moving towards a net debt-zero position. The reaffirmed guidance for the Acquired Group also indicates positive future outlook.
Sudarshan Chemical Industries Limited has released an investor presentation for the quarter and half-year ended September 30, 2026. The presentation, made available on November 6, 2026, details the unaudited financial results (standalone and consolidated) and was presented at an investor call on the same day at 04:00 p.m. IST.
The company highlighted significant achievements and updates from Q2 FY27, including the successful completion of the acquisition of Alu dyes for CHF 7 million, which secures long-term continuity for the business. They also completed the sale of VP4 Frankfurt GmbH for EUR 75.8 million, with proceeds intended for debt prepayment, moving the company closer to a net debt-zero position.
Financially, for Q2 FY27, the 'One Sudarshan' consolidated reported EBITDA was ₹126 crore, a 38.6% increase year-on-year, with Business EBITDA at ₹126 crore, up 38.6%. Revenue from operations for 'One Sudarshan' stood at ₹868 crore, a 22.0% increase YoY. For H1 FY27, consolidated reported EBITDA was ₹243 crore, a 36.3% increase YoY, and Revenue from operations was ₹1,636 crore, up 22.1% YoY.
The presentation also touched upon the integration of Sudarshan and Heubach, aiming to create a global pigment leader. Key innovation updates included new shades for cell phones and advancements in cosmetic and plastic applications. The company reaffirmed its FY27 guidance for the Acquired Group: Sales of approximately €700 million and EBITDA of approximately €35 million.
What to do with a filing like this
Sudarshan Chemical Industries Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sudarshan Chemical Industries Limited. Read the original for the full detail.